Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial

Patients with newly resected stage II melanoma (n = 104) were randomized to receive adjuvant vitamin D3 (100,000 IU every 50 days) or placebo for 3 years to investigate vitamin D3 protective effects on developing a recurrent disease. Median age at diagnosis was 50 years, and 43% of the patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Harriet, Spadola, Giuseppe, Tosti, Giulio, Mandalà, Mario, Minisini, Alessandro M., Queirolo, Paola, Aristarco, Valentina, Baldini, Federica, Cocorocchio, Emilia, Albertazzi, Elena, Zichichi, Leonardo, Cinieri, Saverio, Jemos, Costantino, Mazzarol, Giovanni, Gnagnarella, Patrizia, Macis, Debora, Tedeschi, Ines, Salè, Emanuela Omodeo, Stucci, Luigia Stefania, Bonanni, Bernardo, Testori, Alessandro, Pennacchioli, Elisabetta, Ferrucci, Pier Francesco, Gandini, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226808/
https://www.ncbi.nlm.nih.gov/pubmed/34199802
http://dx.doi.org/10.3390/nu13061931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226808/
https://www.ncbi.nlm.nih.gov/pubmed/34199802
http://dx.doi.org/10.3390/nu13061931

Ejemplares similares